• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21959 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2016     NIHR Health Technology Assessment programme Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pembrolizumab (Keytruda) for platinum-resistant, recurrent or metastatic head and neck cancer
2016     HAYES, Inc. Positron Emission Tomography (PET) for Alzheimer disease
2016     NIHR Horizon Scanning Centre (NIHR HSC) Molgramostim inhalation for autoimmune pulmonary alveolar proteinosis
2016     Penn Medicine Center for Evidence-based Practice (CEP) Mindfulness-based stress reduction interventions for nurses
2016     NIHR Horizon Scanning Centre (NIHR HSC) AM-111 for acute sensorineural hearing loss - first line
2016     HAYES, Inc. myRisk Hereditary Cancer (Myriad)
2016     NIHR Horizon Scanning Centre (NIHR HSC) Cryopreserved human placental tissue (Stravix) for wound repair
2016     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for post-operative opioid prescribing
2016     NIHR Health Technology Assessment programme The effectiveness, acceptability and cost-effectiveness of psychosocial interventions for maltreated children and adolescents: an evidence synthesis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Tremelimumab for unresectable pleural or peritoneal malignant mesothelioma – second and third line
2016     HAYES, Inc. Prolaris prostate cancer prognostic test
2016     NIHR Health Technology Assessment programme UNderstanding uptake of Immunisations in TravellIng aNd Gypsy communities (UNITING): a qualitative interview study
2016     NIHR Horizon Scanning Centre (NIHR HSC) Selumetinib with radioactive iodine therapy for differentiated thyroid cancer – first line
2016     HAYES, Inc. Cariprazine (Vraylar) for schizophrenia and acute manic or mixed episodes in bipolar I disorder
2016     NIHR Health Services and Delivery Research programme Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England
2016     Andalusian Health Technology Assessment Area (AETSA) Nitric oxide as a treatment of pulmonary hypertension in preterm infants
2016     NIHR Health Technology Assessment programme UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2016     NIHR Horizon Scanning Centre (NIHR HSC) Eteplirsen for Duchenne muscular dystrophy in patients amenable to exon 51 skipping
2016     HAYES, Inc. Combined positron emission tomography and magnetic resonance imaging for breast cancer staging
2016     NIHR Health Services and Delivery Research programme Estimating the risk of adverse birth outcomes in pregnant women undergoing non-obstetric surgery using routinely collected NHS data: an observational study
2016     Andalusian Health Technology Assessment Area (AETSA) Assessment of neuroimaging techniques (MR/ CT) in acute stroke
2016     NIHR Health Services and Delivery Research programme Cross-national comparative mixed-methods case study of recovery-focused mental health care planning and co-ordination: Collaborative Care Planning Project (COCAPP)
2016     NIHR Horizon Scanning Centre (NIHR HSC) DMI-9523 (Ampion) for moderate to severe osteoarthritis of the knee
2016     HAYES, Inc. Concentrated bone marrow aspirate for spinal surgery
2016     Andalusian Health Technology Assessment Area (AETSA) Faecal microbiota transplant for recurrent Clostridium difficile infection
2016     NIHR Health Technology Assessment programme Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis
2016     NIHR Health Technology Assessment programme Can text messages increase safer sex behaviours in young people? Intervention development and pilot randomised controlled trial
2016     NIHR Horizon Scanning Centre (NIHR HSC) SPK-RPE65 gene therapy for inherited retinal dystrophies due to mutations in the RPE65 gene
2016     HAYES, Inc. Disinfection caps with isopropyl alcohol–impregnated sponges for needleless connectors to reduce central line–associated bloodstream infections
2016     Andalusian Health Technology Assessment Area (AETSA) Safety and effectiveness of perfusion machine in solid organ transplantation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Lebrikizumab for severe asthma – second line
2016     HAYES, Inc. iStent trabecular micro-bypass stent (Glaukos Corp.) in combination with cataract surgery for treatment of open-angle glaucoma
2016     Andalusian Health Technology Assessment Area (AETSA) Efficacy, effectiveness and safety of antimicrobial copper surfaces for the reduction of healthcare acquired infections
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pitolisant hydrochloride for obstructive sleep apnoea
2016     HAYES, Inc. Maestro Rechargeable System (EnteroMedics Inc.) for vagal blocking for obesity control
2016     Andalusian Health Technology Assessment Area (AETSA) Update of the Guide for decision-making on the introduction of new genetic tests in the National Health System (GEN Guide)
2016     Adelaide Health Technology Assessment (AHTA) Cataract technologies
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ace-ER (aceneuramic acid - extended release) for GNE myopathy
2016     HAYES, Inc. Magnetic resonance–guided focused ultrasound therapy (ExAblate; InSightec Ltd.) for palliation of painful bone metastases
2016     Andalusian Health Technology Assessment Area (AETSA) Effectiveness of chemotherapy and radiotherapy compared with surgery in advanced laryngeal cancer. Systematic review
2016     Adelaide Health Technology Assessment (AHTA) Cardiac MRI for myocardial stress perfusion and viability imaging in patients with known or suspected coronary artery disease
2016     NIHR Health Services and Delivery Research programme Preparing for Home: a before-and-after study to investigate the effects of a neonatal discharge package aimed at increasing parental knowledge, understanding and confidence in caring for their preterm infant before and after discharge from hospital
2016     HAYES, Inc. Nivolumab (Opdivo) for treatment of non-small cell lung cancer
2016     Andalusian Health Technology Assessment Area (AETSA) Bronchial thermoplasty in patients with severe asthma. Efficacy, safety and efficiency.
2016     Adelaide Health Technology Assessment (AHTA) Magnetic resonance imaging of patients with suspected (non-ischaemic) dilated cardiomyopathies
2016     HAYES, Inc. Pembrolizumab (Keytruda) for unresectable or metastatic melanoma
2016     Andalusian Health Technology Assessment Area (AETSA) Eficacy, safety and efficiency of Negative Pressure Therapy system(V.A.C.) in traumatic and postoperative wounds. Systematic review.
2016     Adelaide Health Technology Assessment (AHTA) Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee (Version 5.0)
2016     NIHR Health Technology Assessment programme UnderstaNding uptake of Immunisations in TravellIng aNd Gypsy communities (UNITING) A qualitative interview study
2016     HAYES, Inc. Sacubitril-valsartan (Entresto) for heart failure
2016     Andalusian Health Technology Assessment Area (AETSA) Efficacy and effectiveness of genetic testing for diagnosis of coronary stenosis. Systematic review
2016     NIHR Health Technology Assessment programme Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review
2016     HAYES, Inc. Synergy bioabsorbable polymer drug-eluting stent system (Boston Scientific) for treatment of coronary artery disease
2016     Andalusian Health Technology Assessment Area (AETSA) Follow up of breast cancer in primary care. Safety and efficiency.
2016     HAYES, Inc. Talimogene laherparepvec (T-VEC; Imlygic) for treatment of unresectable melanoma lesions
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Health technology assessments on medical devices in Europe
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Radiofrequency ablation for the treatment of Barrett's esophagus with high-grade and lowgrade dysplasia: an update
2016     Andalusian Health Technology Assessment Area (AETSA) Orthoses indication in foot deformities in children.
2016     HAYES, Inc. Topera 3D mapping system (RhythmView Workstation and FIRMap) to guide ablation procedures for atrial fibrillation
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk
2016     NIHR Health Technology Assessment programme VivaScope® 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation
2016     HAYES, Inc. Trifluridine-tipiracil (Lonsurf) for refractory metastatic colorectal cancer
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Supply Mandates]
2016     NIHR Health Technology Assessment programme The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation
2016     NIHR Health Technology Assessment programme The use of exploratory analyses within the NICE single technology appraisal process
2016     HAYES, Inc. Ustekinumab (Stelara; Janssen Biotech Inc.) for treatment of psoriatic arthritis
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ixazomib (Ninlaro®) in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma (MM)
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) A mini-health technology assessment of Linear and Radial Endobronchial Ultrasound (EBUS) and Electromagnetic Navigation Bronchoscopy (ENB) in the diagnosis and staging of lung cancer in adults
2016     Agency for Healthcare Research and Quality (AHRQ) Management of gout
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Re-orientation of the Austrian parent-child preventive care programme. Part XII: Economic evaluation of selected screenings during pregnancy]
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Cardiac resynchronization therapy in heart failure
2016     NIHR Health Technology Assessment programme Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment
2016     NIHR Health Services and Delivery Research programme Developing a methodological framework for organisational case studies: a rapid review and consensus development process
2016     Agency for Healthcare Research and Quality (AHRQ) Calcineurin inhibitors for renal transplant
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of biventricular pacing in atrioventricular heart block
2016     Agency for Healthcare Research and Quality (AHRQ) Noninvasive treatments for low back pain
2016     Agency for Healthcare Research and Quality (AHRQ) Management of renal masses and localized renal cancer
2016     NIHR Health Technology Assessment programme Comparing open and minimally invasive surgical procedures for esophagectomy in the treatment of cancer: the ROMIO (Randomised Oesophagectomy: Minimally Invasive or Open) feasibility study and pilot trial
2016     Agency for Healthcare Research and Quality (AHRQ) Home-based primary care interventions
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient cardiac rehabilitation part VII: Economic Evaluation]
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Thrombectomy for ischaemic stroke: patient characteristics, structural requirements and (differential) diagnostics]
2016     National Evidence-based Healthcare Collaborating Agency (NECA) [Development of evidence-based clinical imaging guidelines : to supply the evidence for appropriateness of diagnostic imaging studies and radiation exposure levels of patients]
2016     Health Quality Ontario (HQO) Intrathecal drug delivery systems for cancer pain: a health technology assessment
2016     Adelaide Health Technology Assessment (AHTA) Rapid sepsis detection
2016     Health Quality Ontario (HQO) Intrathecal drug delivery systems for noncancer pain: a health technology assessment
2016     NIHR Health Technology Assessment programme Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model
2016     Health Quality Ontario (HQO) Left ventricular assist devices for destination therapy: a health technology assessment
2016     Health Quality Ontario (HQO) Mechanical thrombectomy in patients with acute ischemic stroke: a health technology assessment
2016     Adelaide Health Technology Assessment (AHTA) MALDI-TOF for detection of antibiotic resistant bacteria
2016     Gesundheit Osterreich GmbH (GOeG) [Recent evidence on drug therapy of psychological and behavioral symptoms in Alzheimer's dementia]
2016     Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment- resistant depression: a systematic review and meta-analysis of randomized controlled trials
2016     Adelaide Health Technology Assessment (AHTA) Transcranial magnetic resonance-guided focused ultrasound and deep brain stimulation for refractory depression
2016     Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment-resistant depression: an economic analysis
2016     Adelaide Health Technology Assessment (AHTA) Gene expression profiling of breast cancer
2016     Health Quality Ontario (HQO) Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: a clinical evidence review
2016     NIHR Horizon Scanning Centre (NIHR HSC) Vepoloxamer for vaso-occlusive crises in sickle cell disease – first line
2016     Adelaide Health Technology Assessment (AHTA) Enhanced liver fibrosis test
2016     The Swedish Council on Health Technology Assessment (SBU) [Anal sphincter injuries]
2016     Health Quality Ontario (HQO) Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: an economic analysis